These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 8881374
1. Triazolines 26: 1-Aryl-5-amido-1,2,3-triazolines, a new group of triazoline anticonvulsants. Effect of 5-substitution on anticonvulsant activity. Kadaba PK. Biomed Pharmacother; 1996; 50(3-4):163-9. PubMed ID: 8881374 [Abstract] [Full Text] [Related]
2. Triazolines. 14. 1,2,3-Triazolines and triazoles, a new class of anticonvulsants. Drug design and structure-activity relationships. Kadaba PK. J Med Chem; 1988 Jan; 31(1):196-203. PubMed ID: 3336019 [Abstract] [Full Text] [Related]
3. Triazolines--XXVII. delta2-1,2,3-triazoline anticonvulsants: novel 'built-in' heterocyclic prodrugs with a unique 'dual-action' mechanism for impairing excitatory amino acid L-glutamate neurotransmission. Kadaba PK, Stevenson PJ, P-Nnane I, Damani LA. Bioorg Med Chem; 1996 Feb; 4(2):165-78. PubMed ID: 8814876 [Abstract] [Full Text] [Related]
4. Rational drug design and the discovery of the delta2-1,2,3-triazolines, a unique class of anticonvulsant and antiischemic agents. Kadaba PK. Curr Med Chem; 2003 Oct; 10(20):2081-108. PubMed ID: 12871087 [Abstract] [Full Text] [Related]
5. Triazolines XIII: delta 2-1,2,3-triazolines, a new class of anticonvulsants. Kadaba PK. J Pharm Sci; 1984 Jun; 73(6):850-2. PubMed ID: 6737279 [Abstract] [Full Text] [Related]
6. Triazolines XV. Anticonvulsant profile of ADD 17014, a potentially unique 1,2,3-triazoline antiepileptic drug, in mice and rats. Kadaba PK, Slevin JT. Epilepsia; 1988 Jun; 29(3):330-7. PubMed ID: 3371287 [Abstract] [Full Text] [Related]
7. N-Substituted 4-amino-3,3-dipropyl-2(3H)-furanones: new positive allosteric modulators of the GABA(A) receptor sharing electrophysiological properties with the anticonvulsant loreclezole. El Hadri A, Abouabdellah A, Thomet U, Baur R, Furtmüller R, Sigel E, Sieghart W, Dodd RH. J Med Chem; 2002 Jun 20; 45(13):2824-31. PubMed ID: 12061884 [Abstract] [Full Text] [Related]
16. Anticonvulsants containing the N-(3-aryl-2-propenoyl) amido pharmacophore. Dimmock JR, Gunda SG, Vashishtha SC, Zello GA, Das U, Nienaber KH, Stables JP, Allen TM, Santos CL. J Enzyme Inhib Med Chem; 2004 Aug 22; 19(4):303-12. PubMed ID: 15558945 [Abstract] [Full Text] [Related]
17. Synthesis and anticonvulsant activity of some new 1,1-bis(4-substituted 1,2,4-triazoline-5-thione-3-yl)-2-methylbutanes. Ergenç N, Ulusoy N, Ekinci AC. Farmaco; 1995 Mar 22; 50(3):189-92. PubMed ID: 7755867 [Abstract] [Full Text] [Related]
18. Anticonvulsant enaminones depress excitatory synaptic transmission in the rat brain by enhancing extracellular GABA levels. Kombian SB, Edafiogho IO, Ananthalakshmi KV. Br J Pharmacol; 2005 Aug 22; 145(7):945-53. PubMed ID: 15912138 [Abstract] [Full Text] [Related]
19. Inhibition of R-[3H]-baclofen binding to rat brain synaptic membranes by a homologous series of phenyl alcohol amides anticonvulsants and their evaluation as GABAB receptor blockers. Meza-Toledo SE, Martínez-Muñoz D, Carvajal-Sandoval G. Arzneimittelforschung; 1998 Nov 22; 48(11):1051-7. PubMed ID: 9850423 [Abstract] [Full Text] [Related]
20. Investigation into new anticonvulsant derivatives of alpha-substituted N-benzylamides of gamma-hydroxy- and gamma-acetoxybutyric acid. Part 5: search for new anticonvulsant compounds. Malawska B, Kulig K, Spiewak A, Stables JP. Bioorg Med Chem; 2004 Feb 01; 12(3):625-32. PubMed ID: 14738973 [Abstract] [Full Text] [Related] Page: [Next] [New Search]